Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Preclinical profile of novel antimigraine agent SB-220453 described

Feb. 8, 1999

Lubeluzole shows good safety but no efficacy in large trial in acute stroke patients

Feb. 8, 1999

Ex vivo studies explain disappointing results with antiadhesion therapy in stroke patients

Feb. 8, 1999

Merck researchers design tachykinin antagonists particularly useful as antiemetics

Feb. 8, 1999

Preliminary clinical results presented for YM-872, a potential therapeutic for stroke

Feb. 5, 1999

CNS-5161 safe for further clinical evaluation as a neuroprotective agent

Feb. 5, 1999

Overview of phase II trials of GV-150526 presented

Feb. 5, 1999

Modulators of nAChR a focus of research at NeuroSearch

Feb. 5, 1999

ABS patent application for epilepsy drug allowed in Japan

Feb. 5, 1999

1,6-Naphthyridine anticonvulsants in research at SmithKline Beecham

Feb. 4, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026